“In our revised submission, we performed extensive additional experiments to fully address the reviewer comments.”
Delighted to share our recent study @BloodJournal from the Ebert Laboratory @DanaFarber linking #ClonalHematopoiesis (CH) and #Gout:
https://doi.org/10.1182/blood.2022015384
Truly wonderful, collaborative effort across disciplines and geographies!
🧵Our latest in @BloodJournal
@coleman_lindsley @c_j_gibson @DanaFarberNews
Older patients with AML undergoing HCT have high rates of relapse & non-relapse mortality
We investigated how outcomes relate to both baseline characteristics and molecular MRD
https://tinyurl.com/4bn76ham
Our analysis of how baseline + remission genetics (MRD) inform outcomes in older AML patients undergoing allo HCT
Congrats @haematognomist who started the project in med school and drove it forward through residency; and @c_j_gibson - longstanding collaborator in HCT genomics https://twitter.com/haematognomist/status/1537835359966531586
🧵Our latest in @BloodJournal
@coleman_lindsley @c_j_gibson @DanaFarberNews
Older patients with AML undergoing HCT have high rates of relapse & non-relapse mortality
We investigated how outcomes relate to both baseline characteristics and molecular MRD
https://tinyurl.com/4bn76ham